![David Moller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Moller
No open positions remaining
Profile
David E.
Moller is currently an Independent Non-Executive Director at Eccogene, Inc. since 2024, an Independent Non-Executive Director at Variant Bio, Inc. starting in 2025, and a Venture Partner at Third Rock Ventures LLC starting in 2025.
Former positions include Vice President-Endocrine & Cardiovascular Research at Eli Lilly & Co., Vice President-Metabolic Disorders at Merck & Co., Inc., Chief Scientific Officer & Executive VP at Poxel SA, Chief Scientific Officer at Sigilon Therapeutics, Inc. from 2018 to 2020, Assistant Professor at Harvard Medical School, and Vice President at Merck Research Laboratories Massachusetts LLC.
Education includes an undergraduate degree from Brown University conferred in 1978 and a doctorate from The University of Cincinnati College of Medicine conferred in 1983.
David Moller active positions
| Companies | Position | Start |
|---|---|---|
Variant Bio, Inc.
 Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Director/Board Member | 01/06/2025 |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Private Equity Investor | 01/06/2025 |
Former positions of David Moller
| Companies | Position | End |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of David Moller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Third Rock Ventures LLC
Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
The University of Cincinnati College of Medicine
 The University of Cincinnati College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Variant Bio, Inc.
Variant Bio, Inc. BiotechnologyHealth Technology Develops therapeutics for human generic diversity | Health Technology |
- Stock Market
- Insiders
- David Moller
